Search research articles
Contact Us
Filters
Showing results (21-30 of 38) with videos related to
Page
of 4
Sort By:
Radiology
|
August 12, 2016
<sup>18</sup>F Fluorocholine Dynamic Time-of-Flight PET/MR Imaging in Patients with Newly Diagnosed Intermediate- to High-Risk Prostate Cancer: Initial Clinical-Pathologic Comparisons
Joon Young Choi, Jaewon Yang, Susan M Noworolski, et al.
Osteoarthritis and Cartilage
|
September 14, 2024
The relationships between patellofemoral bone remodeling, cartilage composition, and vertical loading rate: PET/MRI in isolated patellofemoral osteoarthritis
Rupsa Bhattacharjee, Eric Hammond, Ngarmsrikam Chotigar, et al.
AJR. American Journal of Roentgenology
|
August 1, 2018
Early Response Assessment in Pancreatic Ductal Adenocarcinoma Through Integrated PET/MRI
Zhen J Wang, Spencer Behr, Martin V Consunji, et al.
Breast Cancer Research and Treatment
|
November 2, 2022
Clinical characteristics and outcomes in patients with metastatic breast cancer and pseudocirrhosis: a single center retrospective cohort study
Laura A Huppert, Zak Walker, Moming Li, et al.
Plos One
|
June 2, 2021
Outcomes after high-dose radiation in the management of neuroendocrine neoplasms
Katherine S Chen, Courtney Lawhn-Heath, Spencer Behr, et al.
Clinical and Translational Gastroenterology
|
April 27, 2021
Burden of Ionizing Radiation in the Diagnosis and Management of Necrotizing Pancreatitis
Nikhil R Thiruvengadam, Janille Miranda, Christopher Kim, et al.
Endocrine-Related Cancer
|
January 12, 2026
Cabozantinib for Advanced Grade 3 Neuroendocrine Tumors: Subgroup Analysis of the Phase 3 CABINET Trial (Alliance A021602)
Jonathan R Strosberg, Tyler Zemla, Susan Geyer, et al.
Theranostics
|
January 7, 2020
<sup>18</sup>F-Labeled, PSMA-Targeted Radiotracers: Leveraging the Advantages of Radiofluorination for Prostate Cancer Molecular Imaging
Rudolf A Werner, Thorsten Derlin, Constantin Lapa, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 5, 2025
Imaging Efficacy of [<sup>18</sup>F]CTT1057 PET for the Detection of PSMA-Positive Tumors Using Histopathology as Standard of Truth: Results from the GuideView Phase 2/3 Prospective Multicenter Study
Andrei Iagaru, Jose F Suarez, Spencer Behr, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
May 16, 2018
Quantification of <sup>89</sup> Zr-Iron oxide nanoparticle biodistribution using PET-MR and ultrashort TE sequences
Caroline D Jordan, Misung Han, Sravani Kondapavulur, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 38) with videos related to
Sort By:
Page
of 4
Radiology
|
August 12, 2016
<sup>18</sup>F Fluorocholine Dynamic Time-of-Flight PET/MR Imaging in Patients with Newly Diagnosed Intermediate- to High-Risk Prostate Cancer: Initial Clinical-Pathologic Comparisons
Joon Young Choi, Jaewon Yang, Susan M Noworolski, et al.
Osteoarthritis and Cartilage
|
September 14, 2024
The relationships between patellofemoral bone remodeling, cartilage composition, and vertical loading rate: PET/MRI in isolated patellofemoral osteoarthritis
Rupsa Bhattacharjee, Eric Hammond, Ngarmsrikam Chotigar, et al.
AJR. American Journal of Roentgenology
|
August 1, 2018
Early Response Assessment in Pancreatic Ductal Adenocarcinoma Through Integrated PET/MRI
Zhen J Wang, Spencer Behr, Martin V Consunji, et al.
Breast Cancer Research and Treatment
|
November 2, 2022
Clinical characteristics and outcomes in patients with metastatic breast cancer and pseudocirrhosis: a single center retrospective cohort study
Laura A Huppert, Zak Walker, Moming Li, et al.
Plos One
|
June 2, 2021
Outcomes after high-dose radiation in the management of neuroendocrine neoplasms
Katherine S Chen, Courtney Lawhn-Heath, Spencer Behr, et al.
Clinical and Translational Gastroenterology
|
April 27, 2021
Burden of Ionizing Radiation in the Diagnosis and Management of Necrotizing Pancreatitis
Nikhil R Thiruvengadam, Janille Miranda, Christopher Kim, et al.
Endocrine-Related Cancer
|
January 12, 2026
Cabozantinib for Advanced Grade 3 Neuroendocrine Tumors: Subgroup Analysis of the Phase 3 CABINET Trial (Alliance A021602)
Jonathan R Strosberg, Tyler Zemla, Susan Geyer, et al.
Theranostics
|
January 7, 2020
<sup>18</sup>F-Labeled, PSMA-Targeted Radiotracers: Leveraging the Advantages of Radiofluorination for Prostate Cancer Molecular Imaging
Rudolf A Werner, Thorsten Derlin, Constantin Lapa, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 5, 2025
Imaging Efficacy of [<sup>18</sup>F]CTT1057 PET for the Detection of PSMA-Positive Tumors Using Histopathology as Standard of Truth: Results from the GuideView Phase 2/3 Prospective Multicenter Study
Andrei Iagaru, Jose F Suarez, Spencer Behr, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
May 16, 2018
Quantification of <sup>89</sup> Zr-Iron oxide nanoparticle biodistribution using PET-MR and ultrashort TE sequences
Caroline D Jordan, Misung Han, Sravani Kondapavulur, et al.
Page
of 4